Literature DB >> 21669142

Fabrication, characterization and cell cultures on a novel composite chitosan-nano-hydroxyapatite scaffold.

B Palazzo1, A Gallo, A Casillo, P Nitti, L Ambrosio, C Piconi.   

Abstract

This paper deals with the characterizations made during the development of a nano-HAp loaded chitosan scaffold, obtained by the freeze-drying technique combined with a novel in situ crystal growth method. The nano-composites were characterized by a highly porous and interconnected structure. The XRD patterns and calculated domain sizes of the HAp nano-crystals nucleated on the chitosan scaffolds are very similar to the ones recorded for deproteinated bone apatite. Both osteoblasts (MG63) and mesenchimal cells (hMSC) were showing good proliferation and adhesion onto the scaffolds. The presence of extensive filopodia and excellent spreading in and around the interconnected porous structure, indicated a strong cellular adhesion and growth. Moreover a good hMSC osteogenic differentiation has been verified. The observations related to well-developed structure morphology, physicochemical properties and high cytocompatibility suggest that the obtained chitosan-nHA porous scaffolds are potential candidate materials for bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669142     DOI: 10.1177/03946320110241S214

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  2 in total

1.  In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  J Pharm Sci       Date:  2013-12-30       Impact factor: 3.534

2.  Efficient delivery of recombinant human bone morphogenetic protein (rhBMP-2) with dextran sulfate-chitosan microspheres.

Authors:  Yuan-Jun Xia; Hong Xia; Ling Chen; Qing-Shui Ying; Xiang Yu; Li-Hua Li; Jian-Hua Wang; Ying Zhang
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.